Story
Samsung Biologics Makes $1.8 Billion All-Cash Bid for PolyPeptide
South Korea’s Samsung Biologics has announced it will launch a 1.46 billion Swiss francs ($1.81 billion) all-cash tender offer for Swiss contract drugmaker PolyPeptide. The move signals a strategic push into the rapidly expanding market for peptide-based drugs.
Offer Details
The proposed offer is for 44.31 Swiss francs per share, which represents a premium of approximately 6.1% over PolyPeptide's last closing price of 41.75 Swiss francs, according to a Reuters calculation. Both companies confirmed the bid in separate statements.
The public tender offer is expected to begin by the end of August and is anticipated to close by the end of the year, Samsung Biologics said. Following the acquisition, the company plans to pursue a squeeze-out of any remaining minority shareholders and delist PolyPeptide from the SIX Swiss Exchange, making it a wholly owned subsidiary.
Strategic Rationale
This acquisition is set to significantly enhance Samsung Biologics' manufacturing capabilities in peptide-based therapeutics. The company specifically highlighted the fast-growing class of obesity and diabetes treatments, such as GLP-1 drugs, as a key area of focus.
AdBy integrating PolyPeptide's expertise, Samsung Biologics positions itself to capitalize on the high demand for contract manufacturing services in one of the pharmaceutical industry's most dynamic sectors.
Board and Shareholder Support
The deal has received strong backing from key stakeholders. PolyPeptide's board of directors has unanimously recommended that its shareholders accept the offer.
Crucially, PolyPeptide’s largest shareholder, Draupnir Holding, has already agreed to tender all of its shares. Draupnir holds approximately 55.65% of the company, providing a clear path for the acquisition's approval.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.